Featured News
More Lawsuits Filed against Maker of Popular Heartburn Medication after April FDA Recall

Additional lawsuits have been filed against the manufacturers of Zantac, a popular medication used to treat heartburn and acid reflux. The new round of legal action comes after the US Food and Drug Administration (FDA) announced on April 1, 2020, that it is requesting manufacturers of the drug to remove it from the market immediately. According to the FDA, the drug puts users at risk for exposure to N-Nitrosodimethylamine (NDMA), a known carcinogen. The use of the medication could result …

Read More
Featured News
Additional Concerns about Valsartan Arise Amid COVID-19 Pandemic

Valsartan is a hypertension medication and used to treat heart failure. It lowers the risk of heart attack. Valsartan blocks angiotensin II from constricting blood vessels. It also reduces high blood pressure by activating aldosterone. It works by binding with angiotensin type I receptors. It’s an antagonist but works differently than other ACE inhibitors drugs that block the conversion of angiotensin I to angiotensin II. In 2019, users of Valsartan began filing lawsuits against the drug’s manufacturer claiming the use …

Read More
Featured News
Claim Filed against Zantac Maker over the Drug’s Link to Cancer

Legal action is underway regarding the potential link between Zantac heartburn medication and cancer. The US Food and Drug Administration (FDA) is investigating Zantac (ranitidine) after it was determined that the popular heartburn and acid reflux medication contains potentially high levels of N-nitrosodimethylamine (NDMA). NDMA is a known carcinogen. As a result of the finding, sales of the drug have been suspended in US stores. Three pharmaceutical companies have issued recalls for their versions of ranitidine. People are exposed to …

Read More
Featured News
FDA Test Reveals Asbestos in Johnson & Johnson Baby Powder

Johnson & Johnson has recalled 33,000 bottles of its baby powder following FDA testing that determined at least one bottle was contaminated with asbestos, a known carcinogen. The recall affects Johnson & Johnson’s brand baby power sourced from China and distributed in 2018…

Read More
Featured News
Denver Doctor Pleading Guilty to Prescribing Holy Trinity Drug Combination

A Denver doctor recently pled guilty to prescribing patients an illegal combination of drugs known as the Holy Trinity. As reported by the Denver Post, Dr. Andrew Mark Ho agreed to 15 years of supervised release and gave up…

Read More
Featured News
How Long Do I Have to File a Lawsuit If I’m Injured by a Drug?

Suffering an injury from a prescription medication you assumed was safe is devastating. Despite claims of effectiveness and safety, prescription drugs hurt people every day. Many of these injuries are serious – some are even fatal. Nothing can give you back the life you had before you were injured by a dangerous drug…

Read More

Category: Consumer Information

Johnson & Johnson has recalled 33,000 bottles of its baby powder following FDA testing that determined at least one bottle was contaminated with asbestos, a known carcinogen. The recall affects Johnson & Johnson’s brand baby power sourced from China and distributed in 2018…

blood pressure

A voluntary recall has been issued for several medications used to control blood pressure and treat heart failure. The recall was issued after an impurity in the medication’s active ingredient, valsartan, was linked to cancer. The US recall came after 22 other countries issued recalls of their own. Chemical Linked to Cancer According to the statement issued by the US Food and Drug Administration regarding the recall, “[It’ is ] due to an impurity, N-nitrosodimethylamine (NDMA), which was found in …

March 24, 2015 – Eighteen-year old high school student, Aaron Young, has filed what is believed to be the first lawsuit associated with an outbreak of CRE at UCLA. In the lawsuit, Young alleges Olympus—the largest worldwide manufacturer of endoscopes—was negligent for selling an endoscope which could spread dangerous bacteria such as CRE (Carbapenem-resistant Enterobacteriaceae). Young remains hospitalized, and is being treated for the CRE infection after being exposed to an endoscope which may have been contaminated with the bacteria, …

February 17, 2015 – The Daiichi Sankyo Co Ltd and its US subsidiary will pay $39 million to the US government and individual state Medicaid programs in response to a lawsuit filed against the company accusing them of paying doctors kickbacks to prescribe its drugs. The whistleblower lawsuit was filed by former sales representative Kathy Fragoules. As the result of coming forward, Fragoules will receive more than $6 million of the settlement. The lawsuit claimed the “speaking fees” paid to …

Have you been affected by a drug or device listed?